Total Payments
$810,267
2024 Payments
$87,188
Companies
53
Transactions
1,994
Medicare Patients
1,220
Medicare Billing
$92,129
Payment Breakdown by Category
Other$715,931 (88.4%)
Travel$57,284 (7.1%)
Food & Beverage$28,680 (3.5%)
Consulting$8,200 (1.0%)
Research$112.50 (0.0%)
Education$59.67 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $715,931 | 479 | 88.4% |
| Travel and Lodging | $57,284 | 251 | 7.1% |
| Food and Beverage | $28,680 | 1,248 | 3.5% |
| Consulting Fee | $8,200 | 5 | 1.0% |
| Unspecified | $112.50 | 3 | 0.0% |
| Education | $59.67 | 8 | 0.0% |
Payments by Type
General
$810,155
1,991 transactions
Research
$112.50
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $404,303 | 767 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $237,578 | 390 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $149,192 | 289 | $0 (2024) |
| Abbott Laboratories | $5,431 | 80 | $0 (2024) |
| Medtronic MiniMed, Inc. | $3,061 | 29 | $0 (2020) |
| ABBVIE INC. | $2,028 | 23 | $0 (2024) |
| Novo Nordisk Inc | $1,529 | 99 | $0 (2024) |
| Shire North American Group Inc | $1,396 | 18 | $0 (2019) |
| Tandem Diabetes Care, Inc. | $659.14 | 15 | $0 (2024) |
| Medtronic, Inc. | $631.27 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $87,188 | 232 | Lilly USA, LLC ($82,659) |
| 2023 | $92,082 | 267 | Lilly USA, LLC ($83,304) |
| 2022 | $97,348 | 225 | Lilly USA, LLC ($82,132) |
| 2021 | $46,539 | 158 | SANOFI-AVENTIS U.S. LLC ($20,935) |
| 2020 | $97,500 | 208 | AstraZeneca Pharmaceuticals LP ($67,859) |
| 2019 | $143,145 | 326 | Lilly USA, LLC ($76,346) |
| 2018 | $132,585 | 303 | AstraZeneca Pharmaceuticals LP ($45,564) |
| 2017 | $113,880 | 275 | AstraZeneca Pharmaceuticals LP ($63,354) |
All Payment Transactions
1,994 individual payment records from CMS Open Payments — Page 1 of 80
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $4.50 | General |
| Category: Diabetes Care | ||||||
| 12/05/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Endocrinology | ||||||
| 12/03/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $19.23 | General |
| Category: Endocrinology | ||||||
| 11/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $2.82 | General |
| Category: Diabetes Care | ||||||
| 11/20/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/14/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $25.38 | General |
| Category: Insulin Pump | ||||||
| 11/14/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $23.32 | General |
| 11/13/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Endocrinology | ||||||
| 11/06/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $24.61 | General |
| 10/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: Diabetes Care | ||||||
| 10/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/21/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 10/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| Category: Diabetes Care | ||||||
| 10/17/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: Endocrinology | ||||||
| 10/16/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Endocrinology | ||||||
| 10/15/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $10.96 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/08/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/02/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $6.09 | General |
| Category: Diabetes Care | ||||||
| 10/02/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $3.97 | General |
| Category: Diabetes Care | ||||||
| 10/02/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $0.89 | General |
| Category: Diabetes Care | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| NN2211-3965 | Novo Nordisk Inc | $37.50 | 1 |
| Real World Evidence Bydureon Project EQW BCB402 MTC registry | AstraZeneca Pharmaceuticals LP | $37.50 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 285 | 354 | $87,670 | $22,659 |
| 2022 | 4 | 304 | 382 | $71,361 | $25,092 |
| 2021 | 5 | 324 | 386 | $65,886 | $27,503 |
| 2020 | 6 | 307 | 345 | $41,701 | $16,875 |
Total Patients
1,220
Total Services
1,467
Medicare Billing
$92,129
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 159 | 226 | $54,014 | $14,077 | 26.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 52 | $17,160 | $4,825 | 28.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $4,917 | $1,489 | 30.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 41 | $6,683 | $1,408 | 21.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $4,896 | $859.02 | 17.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 186 | 263 | $47,421 | $16,988 | 35.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 65 | 65 | $16,848 | $5,809 | 34.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 36 | $4,158 | $1,208 | 29.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 18 | 18 | $2,934 | $1,088 | 37.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 149 | 204 | $31,416 | $13,685 | 43.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 81 | 81 | $20,412 | $7,618 | 37.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 64 | 71 | $7,100 | $3,182 | 44.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 14 | 14 | $4,606 | $1,976 | 42.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 16 | 16 | $2,352 | $1,042 | 44.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 149 | 184 | $21,662 | $8,984 | 41.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 48 | 48 | $10,224 | $4,085 | 40.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 34 | 34 | $4,358 | $1,640 | 37.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 51 | 54 | $4,260 | $1,585 | 37.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 13 | 13 | $657.00 | $374.30 | 57.0% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2020 | 12 | 12 | $540.00 | $207.02 | 38.3% |
About Dr. Neil Schaffner, M.D
Dr. Neil Schaffner, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Opelika, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184684953.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Neil Schaffner, M.D has received a total of $810,267 in payments from pharmaceutical and medical device companies, with $87,188 received in 2024. These payments were reported across 1,994 transactions from 53 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($715,931).
As a Medicare-enrolled provider, Schaffner has provided services to 1,220 Medicare beneficiaries, totaling 1,467 services with total Medicare billing of $92,129. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Opelika, AL
- Active Since 03/24/2006
- Last Updated 09/10/2013
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1184684953
Products in Payments
- MOUNJARO (Drug) $239,475
- FARXIGA (Drug) $204,401
- TRULICITY (Drug) $148,513
- TOUJEO (Drug) $55,263
- SOLIQUA (Drug) $42,529
- BYDUREON (Drug) $33,123
- SOLIQUA 100/33 (Drug) $18,356
- TOUJEO (Biological) $18,279
- SOLIQUA 100/33 (Biological) $14,430
- FREESTYLE LIBRE 3 (Device) $4,502
- Minimed 670G System (Device) $3,050
- Synthroid (Drug) $1,736
- NATPARA (Drug) $1,325
- JARDIANCE (Drug) $580.35
- MINIMED 780G (Device) $571.13
- HUMULIN (Drug) $491.72
- Ozempic (Drug) $442.37
- t-slim insulin pump (Device) $434.76
- AFREZZA (Drug) $428.77
- FREESTYLE LIBRE (Device) $336.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.